Formulation Licenses
Registered finished dosage forms (FDF), transferable tech packages and in-development in-licensing pipelines · delivered per target-market approval pathway
Formulation (FDF)
Ubenimex Tablets
Tablets · 10 mg * 9, 15 tablets/carton
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB758)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Aspirin Tablets
Tablets · 0.3 g; 0.5 g
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB757)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Valacyclovir Hydrochloride
— · 0.3 g * 7 tablets/carton
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB756)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Cefprozil Dispersible Tablets
Tablets · 0.25 g * 4, 6, 10, 12 tablets/carton; 0.5 g * 4 tablets/carton
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB755)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Primidone Tablets
Tablets · 50 mg * 30 tablets/bottle; 250 mg * 30 tablets/bottle
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB754)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Lithium Carbonate Tablets
Tablets · 0.25 g
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB753)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Phenytoin Sodium Tablets
Tablets · 0.1 g * 100 tablets/bottle
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB752)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Carbamazepine Tablets
Tablets · 0.1 g * 100 tablets/bottle
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB751)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Fluoxetine Hydrochloride Capsules
Capsules · 20 mg * 14, 28 capsules/carton
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB750)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Propranolol Hydrochloride Tablets
Tablets · 10 mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB749)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Losartan Potassium Tablets
Tablets · 100 mg * 7, 14 tablets/carton
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB748)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Lansoprazole Enteric-tablets
tablets · 30 mg * 7, 14 tablets/carton
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB747)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Omeprazole for Injection
for Injection · 40 mg * 1 vial/carton
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB746)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Lansoprazole for Injection
for Injection · 30 mg * 1, 2 vials/carton
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB745)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Mosapride Citrate Capsules
Capsules · 5 mg * 12, 24, 28, 36/carton
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB744)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Compound α-Ketoacid Tablets
Tablets · 0.63 g * 48, 60, 96, 100 tablets/carton
- Therapy
- Nephrology & Urology
- Status
- Official FDF licensing catalog (UB743)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Parecoxib for Injection
for Injection · 40mg*10vials/carton
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB742)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- EU
Formulation (FDF)
Fluticasone Suspension
Suspension · 0.5mg/2ml
- Therapy
- Respiratory
- Status
- Official FDF licensing catalog (UB740)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Bevacizumab Injection
Injection · 40mg/0.8mL
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB739)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Adalimumab Injection
Injection · 40mg/0.8mL
- Therapy
- Immunology & Inflammation
- Status
- Official FDF licensing catalog (UB738)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Abaloparatide injectables
injectables
- Therapy
- Metabolic & Endocrinology
- Status
- Official FDF licensing catalog (UB737)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Etelcalcetide Hydrochloride injectables
injectables
- Therapy
- Metabolic & Endocrinology
- Status
- Official FDF licensing catalog (UB736)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Lanreotide Acetate injectables
injectables
- Therapy
- Metabolic & Endocrinology
- Status
- Official FDF licensing catalog (UB735)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Retatrutide injectables
injectables
- Therapy
- Metabolic & Endocrinology
- Status
- Official FDF licensing catalog (UB734)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Tirzepatide injectables
injectables
- Therapy
- Metabolic & Endocrinology
- Status
- Official FDF licensing catalog (UB733)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Semaglutide injectables
injectables
- Therapy
- Metabolic & Endocrinology
- Status
- Official FDF licensing catalog (UB732)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Semaglutide Oral Tablets
Tablets
- Therapy
- Metabolic & Endocrinology
- Status
- Official FDF licensing catalog (UB731)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Baclofen tablet
tablet · 10mg; 20mg
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB730)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Simvastatine tablet
tablet · 10mg 20mg 40mg 80mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB728)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Pregabaline capsule
capsule · 75mg; 300mg
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB727)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Paroxetine HCl tablet
tablet · 10mg 20mg 30mg 40mg
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB726)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Memantine HCl tablet
tablet · 5mg 10mg
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB725)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Lamotrigine ER tablet
tablet · 25mg 50mg 100mg 200mg 250mg 300mg
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB724)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Felodipine ER tablet
tablet · 2.5mg 5mg 10mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB723)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Celecoxib capsule
capsule · 50mg 100mg 200mg 400mg
- Therapy
- Immunology & Inflammation
- Status
- Official FDF licensing catalog (UB722)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States, China
Formulation (FDF)
Ciprofloxacin HCl tablet
tablet · 250mg 500mg
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB721)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States, China
Formulation (FDF)
Valacyclovir HCl tablet
tablet · 500mg 1g
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB720)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Acyclovir tablet
tablet · 400mg 800mg
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB719)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Midodrine HCl tablet
tablet · 2.5mg; 5mg; 10mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB718)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Bumetanide tablet
tablet · 0.5mg 1mg 2mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB717)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Letrozole tablet
tablet · 2.5mg
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB716)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States, China
Formulation (FDF)
Anastrozole tablet
tablet · 1mg
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB715)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States, China
Formulation (FDF)
Binaprofen injection
injection · 94.85mg/4ml
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB707)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Polyvinyl Alcohol Eye Drops
Eye Drops · 10ml/0.14g
- Therapy
- Ophthalmology
- Status
- Official FDF licensing catalog (UB685)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Azilsartan Potassium Tablets
Tablets
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB682)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Trastuzumab injection
injection · 150mg/vial
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB654)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Tocilizumab injection
injection · 80mg(4ml)/vial
- Therapy
- Immunology & Inflammation
- Status
- Official FDF licensing catalog (UB653)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Infliximab injection
injection · 100mg/vial
- Therapy
- Immunology & Inflammation
- Status
- Official FDF licensing catalog (UB652)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China